No title
Aim: We explored preferences for prognostic test performance characteristics and error tolerance in decisions regarding withdrawal or continuation of life-sustaining therapy (LST) after cardiac arrest in a diverse cohort of medical providers. Methodology: We distributed a survey through professional societies and research networks. We asked demographic characteristics, preferences for prognostic t
